Vorinostat in Patients With Primary Cutaneous T-Cell Lymphoma

Clinical trial NCT00958074 · TERMINATED

Trial details

NCT number: NCT00958074
Sponsor: University of Washington
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous T-cell Lymphoma Stage I Cutaneous T-cell Lymphoma Stage II Cutaneous T-cell Lymphoma Stage III Cutaneous T-cell Lymphoma Stage IV

Start date: 2009-07-01
Primary completion: 2013-02-01
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.